Last Updated: June 22, 2026

MINOCYCLINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Minocycline patents expire, and what generic alternatives are available?

Minocycline is a drug marketed by Aurobindo Pharma, Impax Labs, Sun Pharm Inds Inc, Torrent, Watson Labs, Watson Labs Teva, Zydus, Alkem Labs Ltd, Aurobindo Pharma Ltd, Barr Labs Inc, Impax Labs Inc, Lupin, Pharmobedient, Rising, Sandoz, Sun Pharm, Sun Pharm Inds Ltd, Zydus Pharms, Chartwell Rx, Regcon Holdings, Strides Pharma Intl, Sun Pharm Industries, and Triax Pharms. and is included in twenty-seven NDAs.

The generic ingredient in MINOCYCLINE is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Minocycline

A generic version of MINOCYCLINE was approved as minocycline hydrochloride by WATSON LABS on December 30th, 1991.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for MINOCYCLINE?
  • What are the global sales for MINOCYCLINE?
  • What is Average Wholesale Price for MINOCYCLINE?

US Patents and Regulatory Information for MINOCYCLINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 091118-007 Dec 3, 2019 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Triax Pharms MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET;ORAL 050451-002 Aug 10, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Barr Labs Inc MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 065485-003 Mar 17, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.